Chimerix Inc (CMRX)
0.9835
+0.01
(+0.87%)
USD |
NASDAQ |
May 22, 13:15
Chimerix Cash from Operations (Quarterly): -17.52M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -17.52M |
December 31, 2023 | -14.59M |
September 30, 2023 | -17.93M |
June 30, 2023 | -14.34M |
March 31, 2023 | -22.22M |
December 31, 2022 | -19.99M |
September 30, 2022 | 7.128M |
June 30, 2022 | -10.56M |
March 31, 2022 | -23.45M |
December 31, 2021 | -34.02M |
September 30, 2021 | -15.29M |
June 30, 2021 | -12.72M |
March 31, 2021 | -37.90M |
December 31, 2020 | -9.045M |
September 30, 2020 | -8.299M |
June 30, 2020 | -7.874M |
March 31, 2020 | -10.82M |
December 31, 2019 | -3.469M |
September 30, 2019 | -42.16M |
June 30, 2019 | -13.82M |
March 31, 2019 | -15.73M |
December 31, 2018 | -8.30M |
September 30, 2018 | -12.88M |
June 30, 2018 | -14.04M |
March 31, 2018 | -18.51M |
Date | Value |
---|---|
December 31, 2017 | -12.12M |
September 30, 2017 | -11.38M |
June 30, 2017 | -13.00M |
March 31, 2017 | -13.62M |
December 31, 2016 | -9.697M |
September 30, 2016 | -12.93M |
June 30, 2016 | -12.55M |
March 31, 2016 | -28.64M |
December 31, 2015 | -32.92M |
September 30, 2015 | -24.93M |
June 30, 2015 | -23.02M |
March 31, 2015 | -18.84M |
December 31, 2014 | -16.87M |
September 30, 2014 | -11.45M |
June 30, 2014 | -9.637M |
March 31, 2014 | -9.116M |
December 31, 2013 | -6.785M |
September 30, 2013 | -5.144M |
June 30, 2013 | -7.585M |
March 31, 2013 | -6.045M |
December 31, 2012 | -4.649M |
September 30, 2012 | 12.36M |
June 30, 2012 | -4.68M |
March 31, 2012 | -4.907M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-42.16M
Minimum
Sep 2019
7.128M
Maximum
Sep 2022
-16.44M
Average
-14.46M
Median
Cash from Operations (Quarterly) Benchmarks
UFP Technologies Inc | 10.65M |
Dentsply Sirona Inc | 25.00M |
Arbutus Biopharma Corp | -19.30M |
Pacira BioSciences Inc | 49.10M |
Karyopharm Therapeutics Inc | -43.72M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | 8.675M |
Cash from Financing (Quarterly) | 0.208M |
Free Cash Flow | -64.44M |
Free Cash Flow Per Share (Quarterly) | -0.1966 |
Free Cash Flow Yield | -73.74% |